Understanding Individual Intraocular Pressure Response to Treatment with Latanoprost and Timolol

Area of Science:

• Ophthalmology
• Pharmacology
• Physiology

Background:

• Intraocular pressure (IOP) management is crucial for preventing vision loss.
• Variable patient responses to IOP-lowering medications necessitate understanding underlying mechanisms.
• Latanoprost and timolol are common treatments, but their efficacy can differ between individuals.

Purpose of the Study:

• To investigate the factors influencing differential IOP responses to latanoprost and timolol.
• To identify predictors of treatment success and failure in healthy volunteers.
• To characterize aqueous humor dynamics (AHD) in relation to drug response.

Main Methods:

• A multicenter, randomized, crossover study involving 106 healthy subjects.
• Bilateral ocular treatment with latanoprost or timolol for 7 days, separated by a 6-week washout.
• Assessment of ocular biometrics, tonometry, and AHD at baseline and post-treatment; responders defined by >15% or >10% IOP reduction.

Main Results:

• Latanoprost elicited a response in 54% of subjects, compared to 27% for timolol (at >15% IOP reduction cutoff).
• Higher baseline IOP was significantly correlated with better responses to both drugs (p < 0.01).
• Low baseline uveoscleral outflow predicted nonresponse to latanoprost; timolol nonresponders frequently responded to latanoprost, but not vice versa.

Conclusions:

• Baseline IOP is a key predictor of response to both latanoprost and timolol.
• Uveoscleral outflow characteristics influence latanoprost efficacy, while timolol response is not clearly linked to AHD.
• Cross-over responsiveness suggests distinct mechanisms of action and potential for sequential therapy.